Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$56.41
pos +0.02
+0.04%
Today's Range: 56.23 - 56.84 | MRK Avg Daily Volume: 8,888,100
Last Update: 05/27/16 - 2:30 PM EDT
Volume: 4,254,760
YTD Performance: 6.76%
Open: $56.50
Previous Close: $56.39
52 Week Range: $45.69 - $61.70
Oustanding Shares: 2,768,025,348
Market Cap: 156,587,193,936
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 6 6
Moderate Buy 0 0 0 0
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.17 2.17 2.08 2.08
Latest Dividend: 0.46
Latest Dividend Yield: 3.31%
Dividend Ex-Date: 06/13/16
Price Earnings Ratio: 34.11
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
34.11 34.60 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
11.35% -4.38% 19.57%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.50 -0.20 -0.06
Net Income -62.60 -0.30 -0.11
EPS -61.60 -0.20 -0.08
Earnings for MRK:
EBITDA 13.92B
Revenue 39.50B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.91 $0.98 $3.73 $3.70
Number of Analysts 8 6 10 9
High Estimate $0.94 $1.00 $3.79 $3.88
Low Estimate $0.88 $0.96 $3.65 $3.34
Prior Year $0.86 $0.96 $3.59 $3.73
Growth Rate (Year over Year) 5.67% 2.08% 3.79% -0.73%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

updateMRK Investor Mtg.

May 24, 2016 | 7:27 AM EDT

MRK - Merck & Co Inc Annual Shareholders Meeting - 9AM

By

David Katz

 | May 18, 2016 | 7:00 AM EDT

We offer 10 names each in the Opportunistic Value portfolio and the Income-Oriented portfolio.

By

Bret Jensen

 | May 17, 2016 | 10:00 AM EDT

It is hard to see much growth in the market overall, until earnings growth returns.

By

David Katz

 | May 11, 2016 | 7:00 AM EDT

The expected legal deluge will be manageable thanks to JNJ's massive size and financial strength.

By

Jim Cramer

 | May 10, 2016 | 6:40 AM EDT

And Joe Papa can't stop the world. 

By

Bret Jensen

 | May 9, 2016 | 11:08 AM EDT

And it's hard to get excited about the second quarter, too.

By

Tony Owusu

 | May 5, 2016 | 8:45 AM EDT

Earnings season continued Thursday with oil prices helping lift the market. 

By

David Katz

 | Apr 20, 2016 | 7:00 AM EDT

Candidates have decried rising drug and medical prices, but there are reasons to like these stocks.

bullishMerck rated new Buy at SocGen

Apr 7, 2016 | 7:45 AM EDT

MRK was initiated with a Buy rating, Societe Generale said. Valuation call, based on an $80 price target. 

By

Jim Cramer

 | Apr 5, 2016 | 11:24 AM EDT

Plus, the bears know where to lurk after a run.

TMO agreed to purchase FEI Company for S4.2 billion dollars this morning. The company ran ...
Hewlett-Packard is ramping today following last night's earnings report. The stock ha...
As we did not fail at key resistance on the way up in the S&P and we also cleared the ...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.